AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth
AirSculpt Technologies (NASDAQ:AIRS) executives said the body contouring company has returned to same-store sales growth after more than two years of declines, while outlining plans to expand services tied to GLP-1 weight-loss drug side effects and eventually resume clinic growth across the U.S. Ch
MarketBeat ·